Current research on Muscular Dystrophies (MD) suggests that its occurrence is closely related to several mechanisms, including gene mutations, dystrophin deficiency, and alterations in the Akt/mTOR/p70S6K signaling pathway. This evidence concerns the gene RPS6KB1 and hyperinsulinemic hypoglycemia, familial, 4.